Trial Profile
Ocsaar and CYP2C9 Ploymorphism, Is There a Connection Between Pharmacokinetics, Pharmacodynamics and Pharmacogenetics?
Status:
Not yet recruiting
Phase of Trial:
Clinical Phase Unknown
Latest Information Update: 09 Nov 2021
Price :
$35
*
At a glance
- Drugs Losartan (Primary) ; Valsartan (Primary)
- Indications Hypertension
- Focus Pharmacogenomic; Therapeutic Use
- 26 Aug 2008 New trial record.